1. Case Report: Presumed Optic Neuropathy after Amiodarone and then Dronedarone for Treatment of Atrial Fibrillation
- Author
-
Idit Maharshak, Hillel Steiner, and Michael Paul
- Subjects
Male ,medicine.medical_specialty ,genetic structures ,Vision Disorders ,Visual Acuity ,Amiodarone ,Drug Substitution ,Optic neuropathy ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,Atrial Fibrillation ,Optic Nerve Diseases ,Medicine ,Humans ,Adverse effect ,Dronedarone ,Aged, 80 and over ,business.industry ,Atrial fibrillation ,medicine.disease ,eye diseases ,Ophthalmology ,030221 ophthalmology & optometry ,Cardiology ,Visual Fields ,business ,Complication ,Anti-Arrhythmia Agents ,030217 neurology & neurosurgery ,Optometry ,medicine.drug - Abstract
Significance Amiodarone and dronedarone have recognized ophthalmological adverse effects including optic neuropathy. The recognition of optic neuropathy as a complication of amiodarone and dronedarone treatment may enable withdrawing the drug and accordingly preventing permanent vision loss. Purpose This study aimed to describe a case of optic neuropathy after substitution of amiodarone with dronedarone for treatment of atrial fibrillation. Case report An 81-year-old man treated with dronedarone for atrial fibrillation after amiodarone had caused tremor developed sequential permanent vision loss in both eyes. Conclusions The importance of timely recognition of optic neuropathy as a complication of amiodarone and dronedarone treatment may enable discontinuing the drug, thus preventing permanent vision loss.
- Published
- 2020